Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
38%
Ph phase_2
1
13%
Ph phase_4
2
25%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
Phase 4Post-market surveillance
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(5)

Detailed Status

Completed5
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 33 (50.0%)
Phase 42 (33.3%)

Trials by Status

not_yet_recruiting113%
completed563%
recruiting225%

Recent Activity

2 active trials
Showing 5 of 8
not_yet_recruiting

Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®) in Treating Acute Ischemic Stroke

NCT07519889
recruitingphase_3

Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.

NCT07201688
completedphase_4

Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window

NCT05752916
recruitingphase_3

Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ

NCT06414499
completedphase_2

Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke

NCT04733742
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07519889

Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®) in Treating Acute Ischemic Stroke

Not Yet Recruiting
NCT07201688Phase 3

Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.

Recruiting
NCT05752916Phase 4

Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window

Completed
NCT06414499Phase 3

Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ

Recruiting
NCT04733742Phase 2

Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke

Completed
NCT04588337

INtravenous TNK for Acute isChemicsTroke in China

Completed
NCT04797013Phase 3

Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ

Completed
NCT02835534Phase 4

The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8